FDA Clearance Tracker · K181537
GLOW800
Last checked: Nov 20, 2026Latest source record: Sep 7, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Sep 7, 2018
Substantially Equivalent
Time to decision
88 days
Received Jun 11, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K181537
- Device name
- GLOW800
- Applicant
- Leica Microsystems (Schweiz) AG
- Applicant location
- Heerbrugg, CH
- Received
- Jun 11, 2018
- Decided
- Sep 7, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- System, X-Ray, Angiographic (IZI)
- Device class
- Class II
- Regulation
- 21 CFR 892.1600
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code IZI. The earliest in FDA's data is K781991, decided Dec 7, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K181537
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Leica Microsystems (Schweiz) AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Leica FL400New device typeDe Novo
DEN180024 · Decided Mar 28, 2019 · 335 days after receipt
Device type: Diagnostic Neurosurgical Microscope Filter (QFX) · Neurology & Neurosurgery
- Leica FL560510(k)
K170239 · Decided Jul 5, 2017 · 160 days after receipt
Device type: System, X-Ray, Angiographic (IZI) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.